Connect with us

HEMP

Trump’s Hemp Ban Recasts Marijuana Seeds as Marijuana

Section 781 tests cannabis seeds by the parent plant’s total THC, not the seed, a change that hits genetics shops harder than gummy aisles.

Published

on

President Trump’s hemp rewrite, now set for December 11, 2026, judges marijuana seeds by the parent plant’s total THC, not by the seed. Sponsors framed the rider as a fix for unregulated gummies. The statute also pulls most high-THC genetics out of the 2018 Farm Bill’s hemp definition.

That seed clause is the part licensed growers, mail-order banks, and home breeders have to live with, even if they never sold a delta-8 drink.

Congress Rewrote Hemp to Count Total THC

On November 12, 2025, the president signed H.R. 5371 into law as Public Law 119-37, the package that ended a long government shutdown. The House had passed it 222-209. Buried in Division B is Section 781, which amends 7 U.S.C. 1639o, the hemp definition Trump himself signed in the 2018 Farm Bill.

The Congressional Research Service later found the act narrowed the federal definition of hemp so that products once treated as hemp fall back under the Controlled Substances Act as marijuana or THC. The old test looked only at delta-9 THC at 0.3 percent by dry weight. The new test uses total tetrahydrocannabinols, including tetrahydrocannabinolic acid, at the same 0.3 percent line.

THCA flower that stayed under 0.3 percent delta-9 by leaving the acid unconverted no longer qualifies. Delta-8, delta-10, and similar isomers are pulled into the same count. Finished hemp-derived cannabinoid products also face a hard per-container ceiling of 0.4 milligrams of total THC plus any other cannabinoids HHS says have similar effects, or are marketed that way.

THE HEMP DEFINITION BEFORE AND AFTER

Rule 2018 Farm Bill Section 781
Plant test 0.3% delta-9 THC, dry weight 0.3% total THC, including THCA
Seeds Hemp if the seed itself stayed under the limit Excluded if the parent plant exceeds 0.3% total THC
Finished cannabinoid products Same dry-weight plant test 0.4 mg combined total per container
Synthetics and non-natural cannabinoids Fought in court and guidance Expressly excluded from hemp

Industrial hemp grown for stalk, fiber, grain, and seed oil is written back in as a named inclusion. Consumable cannabinoid products are the ones the exclusions take out.

Viable Seeds Are Tested by the Parent Plant

Seeds themselves carry almost no THC. Under the 2018 rule, and under a 2022 DEA reading that treated low-THC seeds as hemp, that fact kept mail-order genetics inside interstate commerce. Section 781 ends the test on the seed and moves it to the plant the seed came off.

The amended definition says hemp does not include viable seeds from a Cannabis sativa L. plant that exceeds 0.3 percent total THC, including THCA, “in the plant” on a dry weight basis. Three words do the work. A pack of OG Kush, Gelato, or any other named high-THC cultivar is judged by what that cultivar is known to make, not by a lab result on the dry seed.

Certified seed from a licensed hemp crop that passed its pre-harvest test still fits. Those plants are sampled, the result stays on file, and a crop over the line is supposed to be destroyed rather than harvested. The marijuana seed trade has none of that paperwork. The mother is usually gone, no official test was run, and the statute does not name who should have run one.

Named strain listings fill the gap for anyone who wants to bring a case. A shop that advertises a 20 percent THC cultivar has already described the parent plant. That is why mail-order banks, not basement growers, sit first in the crosshairs.

The 0.4 Milligram Cap Sweeps in Medical CBD

Rep. Andy Harris (R-Md.), who pushed the House language, told colleagues the rider “closes the hemp loophole that has resulted in the spread of unregulated intoxicating hemp-derived products that are being sold online and in gas stations and corner stores across the country.” He added that many of those products are “accessible and attractive to children.”

US senators were promised that this bill protects nonintoxicating CBD products, which is manifestly untrue. The large majority of nonintoxicating CBD products on the marketplace feature more than 0.4 mg of THC per container.

Jonathan Miller, general counsel, U.S. Hemp Roundtable

Full-spectrum oils keep a trace of THC because that is how the extract comes off the plant. The cap is per container, not per serving and not by dry weight, so a bottle that is mostly CBD still fails if the residual THC in the whole vessel clears 0.4 milligrams. Isolate that has been stripped to a true zero is the narrow remainder, and processors say that remainder is hard to make once the input extract itself is treated as an illegal intermediate.

THE NUMBERS BEHIND THE CAP

  • More than 95 percent: Share of hemp extract products the U.S. Hemp Roundtable says the new definition would take off the market.
  • Nearly $30 billion: The group’s figure for annual U.S. hemp-derived product sales tied to that fight.
  • About 300,000 jobs: Roundtable estimate of employment sitting on the same product set.
  • More than $1.5 billion: State tax revenue the group says would go with those sales.

FDA-approved drugs such as plant-derived CBD medicines stay outside the hemp-product definition if they already have an approved application. Everyday full-spectrum tinctures do not get that carve-out. The act also told FDA, within 90 days of enactment, to publish lists of natural cannabinoids, THC-class compounds, and anything marketed as having similar effects, plus more detail on what counts as a container.

Why Seed Banks Face a Federal Mail Problem

Once a seed is no longer hemp, it is marijuana under the Controlled Substances Act, and shipping it across a state line is a federal trafficking problem rather than a farm-bill shipment. In-state sales in a legal marijuana market can still move through licensed channels. The national catalog business cannot.

That catalog business is how a lot of licensed flower actually gets its genetics. Breeders in Colorado, Oregon, or Maine have used the hemp reading to mail seeds to growers in other legal states without a DEA registration. After the new definition applies, those packs need a controlled-substance pathway that almost no seed bank holds.

The U.S. Hemp Roundtable warned the spending bill would ban more than 95 percent of hemp products and called the original 365-day fuse a chance to regulate rather than prohibit. Seed sellers were a smaller lobby inside that campaign. Their product never sat next to candy on a gas-station rack, so it did not drive the floor speeches.

Enforcement against a named-strain website is simpler than raiding a closet grow. The listing is public, the cultivar is a confession, and the carrier is the U.S. mail. Growers on breeding forums have been saying the same thing in blunter terms: the pressure lands on whoever still prints a THC percentage next to a “buy” button.

Tissue Culture Is the Gap Breeders Are Using

The seed sentence is the only place Congress said, in so many words, that the parent plant is the thing being tested. Clones, tissue culture, and pollen sit under the broader phrase “the plant Cannabis sativa L. and any part of that plant.” Cannabis lawyers have split on whether that phrase tests the cutting in the box or the mother it came from.

A clone from a high-THC mother already carries the mother’s leaf chemistry. Published work on drug-type cuttings has found total THC in the vegetative stage far above 0.3 percent, so a clone can fail even on the reading that tests the piece in hand. Tissue culture in a jar is closer to empty of cannabinoids, which is why some banks are moving there.

Donna Campanella, who runs the Colorado seed company Brothers Grimm, has said the firm is standing up a tissue-culture operation in Oklahoma because the bill never names tissue culture or clones, and that in-state pop-up shops would be needed “to sell seeds in every state where it’s legal.” That is a business plan, not a court ruling. The firm that first flagged the clone gap has also said the spirit of the law targets high-THC genetics however they are propagated.

WHAT STILL TRAVELS, AND WHAT DOES NOT

  • Certified hemp seed: Seed off a licensed crop that tested at or under 0.3 percent total THC remains hemp and can still move interstate.
  • In-state marijuana seed: Sales inside a legal state can stay inside that state’s licensed system, with no farm-bill shield for a later shipment out.
  • Tissue culture and clones: Unnamed in the seed clause, and treated by some banks as the remaining route to licensed producers.
  • Named high-THC packs in the mail: The listing plus the parent-plant test is the combination most likely to be treated as marijuana.

Pollen is a thinner file. It carries little THC, it is not a seed, and no agency has written a rule for it. Nobody should want to be the test case.

A 29-Day Delay Expires With Government Funding

Rand Paul (R-Ky.) tried to strip the hemp rider in the Senate and lost; 22 Democrats and Sen. Ted Cruz (R-Texas) voted with him against tabling that amendment. Rep. Thomas Massie (R-Ky.) tried a matching House amendment and did not get it into the final package. The concession they did get was time: the rewrite was written to take effect 365 days after enactment, which pointed at November 12, 2026.

Jim Higdon, cofounder of Cornbread Hemp, said after the first signing that advocates could “get a bill through Congress next year before this 365-day deadline” and that it was time “to remediate the worst of it.” Sen. Chris Van Hollen (D-Md.) and others described the same window as a chance to write a real regulatory bill. What Congress actually passed later was a shorter fuse, tied to another spending fight.

On September 2, 2026, Trump signed H.R. 6500, the Continuing Appropriations and Extensions Act, 2027, after the House agreed 370-48 on September 1 and the Senate had passed it 90-6 on August 8. That law funds the government through December 11, 2026, and moves most of Section 781 to the same date, a 29-day slide from November 12. Cannabinoids the plant cannot naturally make stay on the original November 12, 2026 schedule.

THE CLOCK ON SECTION 781

  1. November 12, 2025: Trump signs H.R. 5371. Section 781 is enacted with a 365-day delay.
  2. August 8, 2026: The Senate passes the next stopgap 90-6, with a hemp date change inside it.
  3. September 1, 2026: The House concurs 370-48.
  4. September 2, 2026: H.R. 6500 is signed. Most of the hemp rewrite moves to December 11, 2026.
  5. November 12, 2026: Exclusions for cannabinoids not naturally produced by the plant take effect.
  6. December 11, 2026: Total-THC testing, the 0.4 milligram cap, and the viable-seed clause take effect, on the same day federal funding runs out.

December 11 is not a new hemp policy. It is the day the next continuing resolution expires, which means the seed problem rides into another must-pass bill. Harris has kept pressing to keep the original ban date. Industry lawyers have been hunting for a longer bridge. Neither fight is finished in the statute that is on the books now.

Industrial Stalks and Grain Stay Legal

Section 781 does not put fiber hemp, grain, hulled seed, or seed oil back on Schedule I. Those uses are listed as industrial hemp, and FDA has already allowed hulled hemp seed, protein powder, and seed oil as food ingredients. A farmer growing for stalk or grain, with seed produced only for those uses, is not in the same bucket as a pack of dessert-cultivar genetics.

The people who lose the farm-bill shield are the ones who used that shield for something Congress now says was never hemp: intoxicating drinks and gummies, THCA flower, full-spectrum CBD over the 0.4 milligram line, and viable seed from plants that make more than 0.3 percent total THC. Licensed marijuana shops pick up some of the drink and gummy demand. They also lose a cheap interstate pipe for the genetics in their rooms.

Seed off a tested hemp cultivar will still move. Seed that grows the flower people actually smoke will need a state license, a local counter, or a method the statute never named. December 11, 2026 is the date that split becomes federal law, unless another spending bill moves it again.

Disclaimer: This article is news reporting on federal hemp and marijuana law and is for information only. It is not legal advice, medical advice, or a guide to buying, selling, shipping, or possessing cannabis seeds or cannabinoid products. Readers who need to know how the statute applies to a business, a shipment, or a medical product should consult a licensed attorney in their state, and patients should talk with a qualified clinician, before acting. Dates, definitions, and product statuses follow the public laws and agency materials cited here and can change if Congress or the courts act again.

Harry is the editor and lead writer of MMJ GAZETTE, an independent title on medical cannabis that he owns and runs, covering the science, patient programs, products and the laws that decide who can use them. Ten years of journalism sit behind the site, the first of them as a reporter and the later ones as an editor, with medical cannabis taking up most of that decade. His reporting is built on the clinical literature and the rulebooks: peer-reviewed trials and systematic reviews, trial registry entries, dosing and safety data, the enabling statutes and program rules for each medical scheme, and the guidance issued to prescribers. Study results are reported with their sample size, comparator and confidence interval, each checked against the paper itself before publication, and a claim that outruns the evidence is cut. When an error is found, the article is corrected and a dated note records the change, in line with the site's public corrections policy. Medical cannabis remains illegal in many places and the articles are not treatment advice, so patients should talk with a clinician who knows their history. Reader questions go to support@mmjgazette.com.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending